期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Role of Smad7 in inflammatory bowel diseases 被引量:1
1
作者 Giovanni Monteleone Roberta Caruso Francesco Pallone 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第40期5664-5668,共5页
Crohn's disease and ulcerative colitis,the major forms of inflammatory bowel diseases(IBD) in man,are complex diseases in which genetic and environmental factors interact to promote an excessive mucosal immune res... Crohn's disease and ulcerative colitis,the major forms of inflammatory bowel diseases(IBD) in man,are complex diseases in which genetic and environmental factors interact to promote an excessive mucosal immune response directed against normal components of the bacterial microflora.There is also evidence that the pathologic process is due to defects in counterregulatory mechanisms,such as those involving the immunosuppressive cytokine transforming growth factor(TGF)-1.Indeed,studies in human IBD tissues and murine models of colitis have documented a disruption of TGF-1 signalling marked by a block in the phosphorylation of Smad3,a signalling molecule associated with the activated TGF-receptor,due to up-regulation of Smad7,an intracellular inhibitor of Smad3 phosphorylation.Knock-down of Smad7 with a specific antisense oligonucleotide restores TGF-1/Smad3 signalling,thus resulting in a marked suppression of inflammatory cytokine production and attenuation of murine colitis.These findings together with the demonstration that Smad7 antisense oligonucleotide is not toxic when administered in mice have paved the way for the development of a Smad7 antisense oligonucleotidebased pharmaceutical compound that is now ready to enter the clinics.In this article we review the available data supporting the pathogenic role of Smad7 in IBD and discuss whether and how Smad7 antisense therapy could help dampen the ongoing inflammation in IBD. 展开更多
关键词 Inflammatory bowel diseases Gut inflam-mation Transforming growth factor-β1 SMAD7 Anti-sense oligonucleotides
下载PDF
Recent advances in cellular and molecular aspects of mammalian retinal ischemia 被引量:1
2
作者 Davide Cervia Giovanni Casini 《World Journal of Pharmacology》 2012年第2期30-43,共14页
Retinal ischemia is a common clinical entity and, due to relatively ineffective treatment, remains a common cause of visual impairment and blindness. Generally, ischemic syndromes are initially characterized by low ho... Retinal ischemia is a common clinical entity and, due to relatively ineffective treatment, remains a common cause of visual impairment and blindness. Generally, ischemic syndromes are initially characterized by low homeostatic responses which, with time, induce injury to the tissue due to cell loss by apoptosis. In this re-spect, retinal ischemia is a primary cause of neuronal death. It can be considered as a sort of fnal common pathway in retinal diseases and results in irreversible morphological and functional changes. This review summarizes the recent knowledge on the effects of ischemia in retinal tissue and points out experimental strategies/models performed to gain better compre-hension of retinal ischemia diseases. In particular, the nature of the mechanisms leading to neuronal damage (i.e., excess of glutamate release, oxidative stress and infammation) will be outlined as well as the potential and most intriguing retinoprotective approaches and the possible therapeutic use of naturally occurring molecules such as neuropeptides. There is a general agreement that a better understanding of the funda-mental pathophysiology of retinal ischemia will lead tobetter management and improved clinical outcome. In this respect, to contrast this pathological state, spe-cifc pharmacological strategies need to be developed aimed at the many putative cascades generated during ischemia. 展开更多
关键词 Cell death GLUTAMATE HYPOXIA inflam-mation NEURODEGENERATION NEUROPEPTIDES Oxidative stress Retinopathies
下载PDF
Attenuated blood-brain barrier dysfunction by XQ-1H following ischemic stroke in hyperlipidemic rats
3
《中国药理学通报》 CAS CSCD 北大核心 2015年第B11期46-47,共2页
Following ischemic stroke, blood-brain barrier (BBB) is disrupted and is further aggravated with the corresponding incidence of hyperlipidemia. BBB breakdown promotes inflammation infiltration into the brain, which ... Following ischemic stroke, blood-brain barrier (BBB) is disrupted and is further aggravated with the corresponding incidence of hyperlipidemia. BBB breakdown promotes inflammation infiltration into the brain, which exacerbates cerebral ischemic injury as a result. Here, we report that 10-O-(N,N-dimethylaminoethyl)-ginkgolide B methanesulfonate (XQ-1H) , a novel analog of ginkgolide B, alleviates BBB breakdown in hyperlipidemic rats and protects endothelial cells against inflammatory response. Middle cerebral artery occlusion (MCAO) modeled is- chemic stroke in rats. Before surgery, these rats were fed a cholesterol-rich diet to induce an experimental hyperlip- idemic condition. Additionally, lipopolysaccharide (LPS) incubation with rat brain microvessel endothelial cells (rBMECs) was applied to mimic hyperlipidemia-induced inflammatory injury of BBB. The results indicated more severe infarct size, increased BBB permeability, excessive secretion of pro-inflammatory cytokines, and exaggerated inflammation infiltration of the brain in hyperlipidemic rats following MCAO when compared to rats fed with normal diet. XQ-1H protected BBB integrity, lessoned brain edema and inflammation penetration, down- regulated MMP- 9 and VCMA-1 expressions, and extenuated ischemic infarction. XQ-1H alleviated LPS-induced inflammatory re- sponse in rBMECs, characterized by promoting cell viability, inhibiting TNF-α, IL-1β, and IL-6 releasing, and downregulating NF-KB inflammatory signal and down- stream proteins, such as VCAM-1 and iNOS. In conclusion, the present study shows that XQ-1H stabilizes BBB function following ischemic stroke in hyperlipidemic rats, and the possible mechanisms may be related to inflammation inhibition. 展开更多
关键词 ISCHEMIC stroke HYPERLIPIDEMIA blood-brain barrier rat brain microvessel ENDOTHELIAL cells inflam-mation XQ-1H
下载PDF
慢性肾衰竭大鼠HIF-1表达对贫血及微炎症状态的影响 被引量:5
4
作者 孙秀丽 冯国徵 +1 位作者 侯国存 尚小梅 《中国医师杂志》 CAS 2016年第10期1479-1483,共5页
目的探讨慢性肾衰竭不同时期缺氧诱导因子-1(HIF-1)的表达对贫血及微炎症状态影响。方法雄性sD大鼠行5/6肾切除制作慢性肾衰竭模型,随机分为两组,假手术组(对照组)和手术组[模型组和促红细胞生成素(EPO)组]。造模成功后,EPO... 目的探讨慢性肾衰竭不同时期缺氧诱导因子-1(HIF-1)的表达对贫血及微炎症状态影响。方法雄性sD大鼠行5/6肾切除制作慢性肾衰竭模型,随机分为两组,假手术组(对照组)和手术组[模型组和促红细胞生成素(EPO)组]。造模成功后,EPO组大鼠皮下注射重组人促红细胞生成素(rhuEPO)40IU/kg,每周2次。实验动物分别于术后第1、2、3个月处死,采集血液和残余肾组织标本,监测BUN、Scr、RBC及CRP;HE染色观察残余肾组织病理改变;免疫荧光染色观察HIF-1在肾脏中的表达部位;Western印迹检测HIF-1的蛋白表达水平。结果(1)与对照组比较,模型组术后第1个月Scr和BUN开始升高(P〈0.05),到第3个月Scr上升达(125.79±14.09)μmoL/L;注射rhuEPO后肾功能无明显变化;(2)对照组肾脏病理无明显改变,手术组术后1个月出现肾小球结构紊乱及周围组织纤维化;术后2个月出现肾小管扩张和肾间质纤维化,伴大量淋巴细胞、单核细胞浸润;第3个月,部分肾小球出现节段性硬化,肾间质局灶性纤维化,上皮萎缩。在注射rhuEPO后,病理改变无明显变化;(3)与对照组比较,模型组RBC于术后第1个月开始逐渐降低(P〈0.05),第3个月RBC降到(3.81±0.43)×10^12/L,但经皮下注射EPO后,相应月份贫血较前有所改善;与对照组比较,模型组CRP于术后第1个月呈微量且持续升高(P〈0.05),第2个月开始下降,注射rhuEPO后,与模型组相比,CRP值差异有统计学意义(P〈0.05);(4)与对照组比较,术后第1个月HIF-1表达开始增加(P〈0.05),第3个月HIF-1核阳性达28±1.32,且HIF-1主要在萎缩扩张的肾小管上皮细胞表达。注射rhuEPO后,相应月份HIF-1的表达逐渐减少。结论HIF-1可改善。肾性贫血及抑制微炎症状态。 展开更多
关键词 肾功能衰竭/代谢/并发症 缺氧诱导因子1/代谢 贫血/代谢/并发症 炎症/代谢/并发症
原文传递
Expression of renal cubilin and its potential role in tubulointerstitial inflammation induced by albumin overload
5
作者 Jurong YANG Yani HE +3 位作者 Haiying SHEN Hanlu DING Kailong LI Huiming WANG 《Frontiers of Medicine》 SCIE CSCD 2008年第1期25-34,共10页
Sustained proteinuria is an independent risk factor leading to kidney fibrosis and end-stage renal fail-ure.Over-reabsorption of filtered proteins,notably albu-min,has been proved to trigger interstitial inflammation ... Sustained proteinuria is an independent risk factor leading to kidney fibrosis and end-stage renal fail-ure.Over-reabsorption of filtered proteins,notably albu-min,has been proved to trigger interstitial inflammation and fibrosis in proteinuric renal disease.Cubilin,an endo-cytic receptor expressed on the renal tubular brush bor-der,is responsible for albumin reabsorption in physiologic condition.However,little is known about whether it is required for activation of tubular cells induced by albu-min overload.In this work,we investigated the change of cubilin expression and its potential role in albumin-induced up-regulation of chemokines synthesis in vivo and in vitro.Twenty-six patients with nephrotic syndrome were enrolled in this study.Proximal tubule uptake of albumin,expression of apical membrane cubilin and infiltrating cells in kidney interstitium were determined by immunocytochemistry.In vitro,the transcription of cubilin in HK2 cells after exposure to albumin was ana-lyzed by real-time PCR.Endocytosis of albumin in HK2 cells was examined by fluorescent microscope.The influ-ence of inhibition of cubilin on albumin-induced expres-sions of monocyte chemoattractant protein 1(MCP-1)and regulated upon activation normal T-cell expressed and secreted(RANTES)was investigated by Western blot.The intensity of luminal cubilin and tubular accu-mulation of albumin were significantly increased in nephrotic kidneys.The expression of MCP-1 and RANTES was up-regulated,and there were spatial rela-tionships in localization between these chemokines and cubilin as well as intracellular albumin in kidney tissues.Infiltration of CD-3 and ED-1-positive cells was predom-inant in tubulointerstitial areas displaying signs of increases of cubilin expression and albumin accumula-tion.In vitro,the transcription of cubilin mRNA in HK2 cells was enhanced after 24 h exposure to albumin in a dose-dependent manner.Inhibition of endocytosis of albumin by antisense cubilin nucleotide markedly reduced expression of MCP-1 and RANTES.Cubilin was required for handling a greater amount of protein in nephrotic status and albumin-induced production of MCP-1 and RANTES by renal tubular cells,which further initiated tubulointerstitial inflammation in proteinuric disease. 展开更多
关键词 ALBUMINS CUBILIN CHEMOKINES interstitial inflam-mation nephrotic syndrome
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部